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Abstract
Telocytes (TCs) represent a new type of interstitial cells, and were 
 discovered by Prof. Popescu and his collaborators from Bucharest in 2005, and 
described as Interstitial Cajal-Like Cells (ICLCs). In 2010, Prof. Popescu and 
Prof.  Faussone-Pellegrini from Florence, based on their expertise in  morphology, 
agreed that in fact ICLCs were a brand-new entity and they renamed them telo-
cytes. TCs are characterized by specific veil- or ribbon-like extensions called 
telopodes. Telopodes aid TCs in forming homo- or hetero-cellular contacts; thus, 
assembling  three-dimensional networks that organizes the stromal and the paren-
chymal components of the organs. TCs can transfer information to neighbor cells 
ensuring a short-distance communication, and remotely by the release a wide 
variety of extracellular vesicles: exosomes, ectosomes, and multivesicular bodies. 
Here, we reviewed the evolution of the interest regarding TCs in different organs, 
in normal and pathological conditions. The main focus was on the role of TCs in 
gastrointestinal tract, urinary bladder, reproductive tract, and heart. This chapter 
sums up information about the possibilities that TCs are capable to behave as sen-
sors/mediators in nervous activity, to represent mesenchymal stem cell precursors 
in adulthood, and to control and determine the differentiation/maturation of other 
cell types either during development or in postnatal life.
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1. Introduction: the telocytes
Discovered 13 years ago, telocytes (TCs) still represent a subject of debate 
regarding their role. TCs were first described in 2005, in the interstitial space sur-
rounding exocrine acini in the pancreas, and considered as cells closely resembling 
the interstitial cells of Cajal (ICCs) by Romanian scientists from Carol Davila 
University of Medicine and Pharmacy in Bucharest, Romania, which entitled their 
first publication Interstitial Cells of Cajal in Pancreas [1]. Subsequent publications 
of this team described these cells under the name of interstitial Cajal-like cells and 
characterized them with the aid of electron microscopy and immunoctyo(histo)
chemistry [2–6]. In 2010, professor Popescu, the Bucharest team leader, along with 
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professor Faussone-Pellegrini, who is considered to be the international leading 
expert in ICCs (the gut pacemaker cells), have agreed that TCs and ICCs can be 
regarded as completely different cell populations based on the ultrastructural 
peculiarities, and went on to give them the name of “telocytes” [7]. In the following 
years, TCs have been described in numerous organs, and appear to be omnipresent 
in stromal space of humans and laboratory mammals where they form networks 
[8–10] by making contacts with each other (homo-cellular contacts). This is 
possible due to their unique and exceptionally long (several tens to hundreds of 
μm) cell prolongations called telopodes [7]. As professor Popescu liked to say “the 
shortest possible definition for telocytes is cells with telopodes” [11]. Telopodes are 
characterized by a succession of thin, filamentous regions (podomers) and dilated 
areas (podoms) with bead-like appearance [12]. TCs were revealed to have a third 
dimension that was only recently observed by FIB-SEM tomography, telopodes 
being represented by a veil- or ribbon-like extensions that compartmentalize the 
interstitial space [13]. Apart from the ability to form networks, TCs also can provide 
local communication with different cells and also to deliver extracellular vesicles 
to establish distant communication [14–18]. A detailed representation of the TCs 
contacts is illustrated in Figure 1.
To find out the function(s) of these cells, many methods of investigation have 
been employed, ranging from classical microscopy—optical and electronic—to 
advanced genomics and proteomics techniques. Thus, differentiation of TCs from 
mesenchymal stem cell adipocytes, fibroblasts, and endothelial cells was achieved 
[19–22].
The discovery and description of TCs have given rise to many controversies. 
From the publication of the first article to the present, the interest generated by TCs 
can be traced in the graph summarizing the number of articles published annually 
in PubMed (Figure 2). Though not yet described in speciality treatises as a distinct 
cellular type, this prospect does not seem to be far, the evidence being the increase 
in the number of articles published in the most prestigious journals such as Nature 
[23–25]. The discussion of these controversies is dealt with in detail by two recent 
reviews, in which there are enough arguments for and against the existence of TCs 
as a new cell type [26, 27]. We believe that in the shortest time new biomarkers will 
Figure 1. 
Artistic representation of a 3D view of the contacts of a telocyte. TCs are regarded as interconnection devices 
due to their homo- and hetero-cellular junctions, as well as to their proximity to structures like blood vessels, 
nerve fibers, and muscle fibers. Image courtesy of Iurie Roatesi. Reproduced with permission from Ref. [75].
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be found to prove the existence of this particular type of cell, and here is just one 
step to the description of their possible functions.
Our attention in this chapter is focused on synthesizing the available informa-
tion relating to the main categories of interest that emerge from the chart shown in 
Figure 3, namely gastrointestinal tract, urinary bladder, reproductive tract, and heart.
1.1 The telocyte network
The ability of these cells to form 3-D stromal networks can be considered 
a discriminant element for their recognition under the light microscope [8], 
Figure 2. 
Trends of publications searched in PubMed with “Telocytes” as a key word between 2010 and 2019.
Figure 3. 
Histogram of publications on telocytes categorized by categories of interest.
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especially because no specific immunomarkers are available [28]. Indeed, the cell 
surface glycoprotein CD34, a marker shared with vascular endothelial cells, is cur-
rently considered one of the most suitable for the immunohistochemical identifi-
cation of the TCs, which are also referred to as CD34+ stromal cells/TCs by some 
authors [29, 30]. Through extensive homo-cellular networks, TCs are believed 
to build the stromal scaffold whose continuity and adaptability guarantees the 
maintenance of the integrity of tissues/organs every time they are subjected to 
mechanical forces, such as distension and stretching. Moreover, TCs are univer-
sally considered key organizers of the connective tissue and eventually, they may 
contribute to the production and shaping of the extracellular matrix (ECM) in 
cooperation with fibroblasts. This has been observed in TCs located in the female 
genital tract where these cells express both estrogen and progesterone receptors 
[4, 31] whose activation is followed by significant changes of the TCs that acquire 
fibroblast-like features and become capable to produce the ECM [8]. Likely, 
the homo-cellular TCs contacts are also involved in the intercellular exchange 
of molecular or ionic signaling. Alongside the aforementioned roles, probably 
shared by all the TCs, many other roles have been attributed to these cells [30]. 
Therefore, each of the TCs subtypes is likely to play its organ-/tissue-specific 
role [8].
Although the TCs homo-cellular contacts are commonly observed, a variety 
of cell-to-cell contacts between TCs and other cell types (referred to as hetero-
cellular contacts) are also observed [8, 32–35]. They consist of minute junctions 
(point contacts, nanocontacts, and planar contacts) whose mean inter-mem-
brane distance is 10–30 nm, but more often by variably extended simple apposi-
tion of the contiguous plasma membranes that might act either as mechanical 
cell-to-cell attachments or as sites of intercellular communication [18]. Among 
these contacts, there are the so-called “stromal synapses” [36], a term used to 
describe those contacts occurring between TCs and several types of connective 
tissue cells such as mast cells, macrophages, myofibroblasts, and fibroblasts 
[8, 18, 35, 37]. The networks built by these hetero-cellular contacts are named 
“mixed networks.” Collectively, the existence of mixed networks in addition to 
the homo-cellular TCs networks, the morphological and immunohistochemical 
differences reported for the TCs among organs and tissues, the existence of TCs 
subtypes, the interactions that TCs make with the ECM and, finally, the TCs 
vicinity to nerve endings and vascular cells, have substantiated the hypothesis 
that these cells may be part of integrated systems playing tissue-/organ-specific 
roles [8, 30, 32, 33, 35, 38].
1.2 Specific roles of the telocyte network: hollow organs
A common role proposed for the 3-D TCs scaffold in the hollow organs is to 
follow organ distension and relaxation avoiding anomalous deformation and 
controlling blood vessels closure or rheology. However, because of the anatomical 
complexity of such districts and the great variety of cell populations herein inter-
acting with the TCs, many other roles are conceivable, suggesting that these cells, as 
connecting devices in the stromal space, might take center stage in the integration 
of all the information coming from the vascular, nervous, and immune systems, as 
well as from tissue-resident stem cells.
The present overview of the literature focused on the spatial organization, mor-
phological, and histochemical peculiarities of the TCs, according to their location in 
different organs. This may help to point out the presumptive roles of the homo- and 
hetero-cellular TCs networks. With this aim, the TCs networks located in some 
representative hollow organs that have been more intensively studied, such as the 
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gastrointestinal and reproductive tracts, the urinary bladder, and in the cardiac paren-
chyma, in both healthy and disease conditions, have been taken into consideration.
2. Gastrointestinal tract
The gastrointestinal tract consists of different hollow organs which have some 
similar and some different shapes and functions. Every organ modifies its lumen 
caliber and thickness several times throughout the day, following food transit. Food 
intake might happen several times per day, with different types and quantities, and 
the food transit varies according to the different regions, from the stomach to the 
colon. The cells of the lining epithelium do not change their shape, while microvilli 
height importantly changes. Under the mucosa, made by the epithelium, the lamina 
propria, and the muscular mucosae, there is the submucosa that has different 
morphological organization and function. Finally, the muscle coat is responsible 
for gastrointestinal contractility. Two motile activities, coordinated by the enteric 
nervous system and the ICCs, are present: peristalsis, a constant ab-oral movement 
that does not importantly modify the lumen caliber, and the relaxation/contraction 
related to food arrival/mixing for digestion and absorption/transit which promotes 
sustained lumen caliber changes. Region-specific mechanical and functional inter-
relationships between all the components of this complex apparatus are at the basis 
of the correct and coordinated behavior of the apparatus.
2.1 Gastrointestinal telocyte network in healthy condition
In the human and mouse gastrointestinal tract, the TCs form widespread 
networks in the mucosa, submucosa, muscle layers, at the myenteric plexus level, at 
the submucosal border of the muscular mucosae, in the circular muscle layer, and 
around nerve strands, blood vessels, funds of gastric glands, and intestinal crypts 
[32, 39]. Immunohistochemically, all the TCs residing in the different layers of the 
gastrointestinal tract wall can be identified as CD34+/PDGFRα+ interstitial cells 
[32]. In the lamina propria and submucosa, the 3D homo-cellular TCs network has 
a structural role, forming the scaffolding that can direct the collagen fibers/bundles 
and define the spaces where the several elements of the connective tissue accommo-
date. Although it cannot be excluded that these TCs could eventually be recruited 
for the ECM synthesis, the abovementioned structural function is likely to be the 
main one. However, the role attributed to the TCs lining the basal-lateral surface of 
the glandular crypts [32, 39], where epithelial stem cells are located is particularly 
intriguing, since these TCs have been proposed to influence the proliferation and 
differentiation of stem cells due to their ability to produce and secrete a variety of 
molecules [40], the close relationships they recurrently establish with the “stem 
cell niches” [34, 40], and the expression on their surface of the functional recep-
tor PDGFRα whose activation is critical in mammalian organogenesis [39]. In this 
context, it is worth mentioning that a very recent study demonstrated that the sub-
epithelial plexus formed by PDGFRα+ TCs acts as a crucial source of Wnt proteins, 
which are essential to support intestinal crypt stem cell proliferation and epithelial 
renewal [23]. In the muscle coat, by both immunohistochemistry (PDGFRα and 
CD34 immunolabeling) and electron microscopy, the TCs processes were observed 
to constitute 3D networks intermingling with those of the ICCs and to establish 
cell-to-cell contacts with them [32, 34]. Interestingly, within the gut muscle layers 
the TCs and ICCs networks can be clearly distinguished based on their different 
immunophenotypes, as the TCs are CD34+/PDGFRα+ and negative for c-kit, 
and vice versa, the ICC are c-kit+ and negative for either CD34 or PDGFRα [32] 
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(Figure 4A–I). This mixed TCs/ICCs meshwork and areas of simple apposition 
occurring between the TCs and the smooth muscle cells have suggested that the 
intramuscular TCs might support the spreading of the slow waves generated by the 
ICCs, which are electrically coupled to the smooth muscle cells, thus contributing 
to the regulation of gastrointestinal motility [32, 41]. In favor of this hypothesis, it 
has been recently reported that the “smooth muscle cells are electrically coupled to 
both ICCs and PDGFRα+ cells (i.e., the TCs) forming an integrated unit called the 
SIP syncytium” [42]. Another possible role attributed to the TCs located in the gut 
muscle coat is that they might eventually differentiate into ICCs. This hypothesis 
is mainly based on the existence of the ICCs/TCs mixed network, where the two 
interstitial cell types are often intercalated (Figure 4I) [32, 34, 37]. In support of 
this hypothesis, despite apoptotic ICCs have been described in the colon of human 
healthy subjects of different ages, no decrease in the number of ICCs was observed 
in relation to aging and no ICCs was ever seen undergoing mitosis [43], while 
mitotic TCs rich in rough endoplasmic reticulum can be detected in the interstitial 
spaces usually occupied by the ICCs (personal unpublished observation). Taken 
together, these data suggest that TCs might represent a pool of ICCs precursors 
being responsible for the physiological replacement of aged ICCs. Furthermore, 
it has been demonstrated that in culture stromal cells expressing CD34 (a typi-
cal marker of the TCs) proliferate and progressively lose their CD34-positivity 
to acquire the c-kit-positivity (a typical marker of the ICCs) [44]. Reasonably, in 
adulthood the TCs, wherever they are located, might be considered as a pool of 
mesenchymal stromal cells and, in the gut, to be important for ICCs renewal [37].
Figure 4. 
TCs and ICCs in the human gastrointestinal tract. TCs and ICCs form intermingled networks in the muscularis 
propria of the human intestine. Representative images of human colon sections double immune-stained for: 
(A–C) CD34 (green) and PDGFRα (red), (D–F) CD34 (green) and c-kit (red), and (G–I) PDGFRα (green) 
and c-kit (red) are shown. Nuclei are counterstained with DAPI (blue). Merge images are shown in the right 
panels. All the TCs are CD34+/PDGFRα+ (A–C), while the ICCs are c-kit+ and negative for either CD34 
(D–F) or PDGFRα (G–I). Scale bar: 50 μm.
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2.2 Telocyte network in gastrointestinal diseases
Inflammatory bowel diseases (IBD), including Crohn’s disease (CD) and 
ulcerative colitis (UC), are complex disorders in which chronic relapsing and 
inflammation progressively evolve into extensive fibrosis of the intestinal wall 
[41, 45]. Both CD and UC are characterized by abdominal pain and diarrhea, 
mainly as a result of the progressive fibrotic process that leads to a stiff intestine 
unable to properly carry out peristalsis and resorptive functions [45–47]. The 
evidence that intestinal dysmotility with a reduction in the number of ICCs is a 
feature of IBD and that the ICCs and TCs networks are intermingled in the gut 
neuromuscular compartment has prompted an investigation of the TCs distribu-
tion either in the terminal ileum of CD patients or in the colon of UC patients 
[32, 41, 48–51]. Interestingly, in both conditions, the gut wall fibrosis was strictly 
paralleled by a reduction in TCs [50, 51]. In fact, in the CD intestinal wall, which 
is histopathologically characterized by discontinuous signs of inflammation 
and fibrosis (referred to as “skip lesions”), TCs were normally distributed in 
all layers of the healthy-looking areas from the mucosa to the subserosa, while 
they were markedly reduced in the fibrotic areas displaying severe architectural 
derangement [50]. In particular, the network of TCs was discontinuous or even 
completely lost among smooth muscle bundles and around myenteric plexus 
ganglia [50]. As far as UC is concerned, TCs were investigated in tissue speci-
mens from both patients in early and those in advanced phases of colonic wall 
fibrotic remodeling [51]. In the early phase, fibrosis is confined to the muscular 
mucosae and submucosa, while in the advanced one it extends affecting wide 
areas of muscle layers and the myenteric plexus. Of note, TCs were significantly 
reduced in the muscular mucosae and submucosa of both early and advanced 
fibrotic UC cases [51]. On the contrary, the intramuscular and myenteric plexus 
TCs networks were severely compromised in the advanced but not in the early 
fibrotic UC cases [51]. Through double immunofluorescence, it was possible to 
further reveal that in both forms of IBD the losses of TCs and ICCs occurred in 
parallel in the muscle layers and around the myenteric ganglia [50, 51]. Based on 
these findings, it has been proposed that the simultaneous reductions in the TCs 
and ICCs might significantly account for intestinal dysmotility in IBD. Several 
assumptions have also been made concerning the possible causes and pathophysi-
ologic implications of this TCs impairment [41, 50, 51]. As reported in the failing 
human heart [41, 52], the progressive alteration in the ECM composition and 
entrapment of TCs in such fibrotic ECM may provoke profound cell sufferance 
and eventually lead to cell death. Both the ECM accumulation/rearrangement 
and the parallel reduction of TCs may profoundly impair their hetero-cellular 
networks with immune cells, fibroblasts, smooth muscle cells, ICCs, blood 
vessels, and nerve endings, thus hampering the TCs intercellular signaling func-
tions [41]. Whether the loss of the TCs might even precede the onset of fibrosis 
rather than being merely a consequence of tissue fibrotic remodeling is difficult 
to demonstrate. In line with the proposed role of TCs as a guide for the correct 
tissue shaping during organ morphogenesis, it cannot be excluded that the loss 
of TCs might contribute to the altered 3D ECM organization in the fibrotic 
intestinal wall [46]. For instance, it has been proposed that the disappearance 
of TCs might favor an uncontrolled activation of ECM synthesizing fibroblasts 
and their transition to profibrotic α-smooth muscle actin (α-SMA)+ myofibro-
blasts [46]. Noteworthy, hetero-cellular contacts between TCs and fibroblasts/
myofibroblasts have been described in different organs, suggesting that the TCs 
could contribute to tissue homeostasis by controlling the synthetic activity of 
such partners through inhibitory signals [46]. In support of this hypothesis, in 
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UC colonic specimens the loss of TCs was paralleled by an increase in the num-
ber of α-SMA+ myofibroblasts [51]. This last observation suggests that during 
pathologic processes a subset of TC could undergo phenotypic changing, possibly 
contributing to the increase in the profibrotic myofibroblast population [41]. 
However, double immunolabeling for CD34 (as TC marker) and α-SMA did not 
reveal the presence of CD34+/α-SMA+ transitioning stromal cells in the colonic 
wall of UC patients, which makes unlikely the aforementioned hypothesis [51]. 
Also, electron microscopy investigations of different pathological tissues (e.g., 
failing human heart, fibrotic skin) have clearly shown that fibrosis is accompa-
nied by TC degenerative processes rather than by activation/transformation into 
myofibroblasts [52, 53]. As the findings in the CD and UC intestinal tissues, a 
loss of TCs have also been reported in the neuromuscular compartment of the 
fibrotic gastric wall of patients with systemic sclerosis, where it likely contrib-
utes to gastric dysmotility clinically manifesting as delayed gastric emptying or 
gastroparesis [54].
Besides IBD, recent evidence suggests that the TCs might be a cell source of 
certain kinds of gastrointestinal stromal tumors (GIST) [55]. While ICCs hyper-
plasia has been identified as a crucial pathogenic feature of KIT-mutant GIST, 
it has been proposed that the TCs could represent the physiological counterpart 
of PDGFRa-mutant GIST and inflammatory fibroid polyps [55]. Indeed, a 
pathogenic relationship between TCs hyperplasia and both inflammatory fibroid 
polyps and PDGFRa-mutant GIST has been suggested. Moreover, the term 
“telocytoma” was proposed for defining inflammatory fibroid polyps, since it 
conveys both the pathogenic (neoplastic) and histotypic (“telocytary”) nature of 
this tumor [55].
3. Human urinary bladder
The urinary bladder is a complex organ which modifies its volume and shapes 
several times during the day following filling and micturition. Filling happens 
gradually during the time while micturition happens in a unique and sustained 
emission of the urine. The cells of the lining epithelium (urothelium) dramati-
cally changes their shape and height; under the urothelium, there are two regions: 
the upper lamina propria (ULP) and the deep lamina propria (DLP), with dif-
ferent morphological organization and function; the detrusor is the muscle coat 
responsible for organ relaxation and contraction. Region-specific mechanical and 
functional interrelationships between all the urinary bladder components are at the 
basis of correct and coordinated behavior.
3.1 Bladder telocyte network in healthy condition
In the bladder, unlike in other organs, a more complex picture comes out 
[33, 35]. As is the case in the gut, the bladder TCs form complex networks and 
make contacts either between themselves or with other cell types; however, 
depending on their location, they show different immunohistochemical properties 
and ultrastructural peculiarities. The main differences are detected between the 
TCs located in the sub-urothelial connective tissue (upper lamina propria, ULP) 
and those located in the submucosa (also referred to as deep lamina propria) and 
detrusor. The TCs in the ULP is PDGFRα+ and CD34- while those in the submu-
cosa and detrusor are CD34+ and PDGFRα- (Figure 5A and B). Moreover, while 
the TCs immediately below the urothelium express only the PDGFRα and form a 
homo-cellular network, the other sub-urothelial TCs are also α-SMA+ (Figure 5A) 
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and under the transmission electron microscope show a larger body and cell 
processes possessing attachment plaques with the connective tissue like the fibro-
nexuses typical of myofibroblasts. Further, these TCs establish extended regions 
of simple apposition with the myofibroblasts, thus forming a 3D mixed network 
(Figure 5A). This mixed network together with the homo-cellular networks that 
the TCs make in the remaining portions of the bladder constitutes the scaffolding 
to guarantee the organ integrity during distention and relaxation [33, 35, 37, 56]. 
However, other specific roles have been assumed for the bladder TCs, particularly 
for those located in the ULP. The TCs lining the urothelium is quite peculiar, 
because of their location and immunolabeling [33, 38]. As already discussed, 
the PDGFRα+ TCs located immediately beneath the intestinal crypts appear to 
be cells engaged in controlling the proliferation and differentiation of the stem 
cells resident in the crypts [23]. Likewise, sub-urothelial TCs could play similar 
functions. Immediately below those TCs, there is the TCs/myofibroblast network 
and both cell types form gap junctions and express the Cx43 protein, are close to 
nerve varicosities, express the vanilloid, the ATP, the purine and the muscarinic 
receptors and contain the cGMP, the target molecule of NO [35]. These features 
support the hypothesis that these cells have a role as intermediaries in propagating 
chemical or electrical stimuli locally generated, as well as a role as the target of 
the paracrine activity of the urothelium and the nervous stimuli [35, 38, 57]. The 
importance of these roles is plenty understood, since the ULP and the urothelium 
constitute a sensory system capable of perceiving mechanical and chemical stimuli 
and whose integrated responses control the efferent pathways on the detrusor and 
the micturition.
Figure 5. 
TCs networks in the human urinary bladder. (A) PDGFRα (green) and α-SMA (red) immunolabeling. A 
monolayer of PDGFRα+ TC lines the urothelium (U). In the remaining upper portion of the lamina propria 
(ULP) a mixed network made by PDGFRα+/α-SMA+ TC (hybrid TC) and α-SMA+ myofibroblasts is 
present. (B) CD34+ TC form a homo-cellular network in the deep lamina propria (DLP) and detrusor (D). 
Scale bar: A, B = 100 μm.
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3.2 Telocytes in bladder diseases
The micturition reflex is the result of a complex integration among involuntary 
and voluntary nervous mechanisms. Several pathological conditions of the low 
urinary tract compromise this function causing detrusor dysfunctionality. The most 
frequent is the idiopathic detrusor overactivity, the neurogenic detrusor overactiv-
ity (NDO), the bladder pain syndrome/interstitial cystitis, and the partial bladder 
outlet obstruction. All these diseases are characterized functionally by excessive 
sensitivity of the detrusor/bladder to filling [58], and histologically by an intense 
inflammation especially in the lamina propria [35, 38, 59, 60]. Since it is well known 
that TCs and myofibroblasts produce cytokines and other molecules able to recruit 
immune cells and express receptors for the cytokines released by the immune cells, 
both cell types likely intervene in the inflammation intensity, quality, and duration. 
Furthermore, in the presence of detrusor hyperactivity, both ULP-TC and myofi-
broblasts showed an increase of the Cx43 protein labeling that was interpreted as 
an augmentation of the gap junctions and signs of cellular activation (clear nuclei 
and larger bodies) [35, 38, 59, 61]. Additionally, the TCs expressing both PDGFRα 
and α-SMA were significantly increased in comparison with controls suggesting a 
shift toward a myofibroblast phenotype [35, 38]. All these cell changes were con-
sidered signs of adaptability because, despite the presence of inflammation, the 3D 
cell network was preserved [38, 59]. However, this integrity not necessarily means 
adequate functionality of the sensory system made by the urothelium and the ULP; 
in fact, the higher thickness of the ULP, due to the intense cell infiltrate and edema, 
forcing the net meshes to enlarge, could cause an increase in the distances among 
the cells, between them and the nerve endings, and between all of them and the 
urothelium, likely affecting the sensitivity to volume changes and the capability of 
responding to the molecules released by the nerve terminals and by the urothelium. 
Finally, because the ULP thickening was uneven alongside the organ [35, 38, 60], 
foci of hypersensitivity could alternate to others less responding, further prejudic-
ing the correct integration of the afferent stimuli [57]. Finally, it was reported 
that the TCs forming the monolayer underlying the urothelium did not show any 
significant changes in hyperactive bladders. These data were explained as follow: 
the location of these TCs could spare them from the damages caused by the cell 
infiltrate. Further, if these TCs are engaged in cell proliferation and differentiation 
of the overlying epithelium, the absence of epithelial cell death signs in NDO might 
account for their sparing.
4. Reproductive system
The female reproductive system includes, besides external sex organs, the inter-
nal sex organs: the ovaries, fallopian tubes, and uterus. Immature at birth, these 
organs continue to develop and reach maturity at puberty when they can produce 
gametes, and to carry a fetus to full term. Fallopian tubes integrity is capital for 
fertilization which usually occurs in the external third of the tubes. The traveling 
zygote will form the blastocyst that will be implanted in the uterine endometrium. 
To obtain and maintain a pregnancy, the integrity and functionality of these organs 
need to be at a maximum.
4.1 Telocytes in uterus and fallopian tubes in healthy condition
Currently, TCs are found in uterine tubes and uterus, including endometrium, 
myometrium, and cervix, and also in the vagina [2, 3, 62–65]. Among the first 
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locations in which TCs were described are the organs of the female genital appara-
tus: the uterus and the fallopian tubes [2, 3, 5, 10, 66]. Since the beginning, their 
characterization was based on conventional microscopy methods and techniques 
such as methylene blue staining and silver impregnation, in situ and in vitro [2, 3], 
followed by the description of the “gold standard” for their identification with the 
aid of electron microscopy [5]. In parallel, various immunohistochemical markers 
have been used to enhance TCs better characterization, which has varied over time 
from vimentin, α-SMA, progesterone receptor, desmin, estrogen receptor, and S100 
protein, to stabilize what we consider nowadays to best describe the phenotype of 
these cells—CD34 and PDGFRα [2, 3, 67]. A book chapter refers to the immuno-
histochemistry of TCs in female genital organs [28]. However, it should be pointed 
out that TCs in the uterus and fallopian tubes express receptors for estrogen and 
progesterone [4, 31]. Nowadays, the most suitable methods for TCs identification 
are electron microscopy and double staining for CD34 and PDGFRα or PDGFRβ or 
vimentin [68, 69].
In the human uterus, TCs establish homo- and hetero-cellular junctions, dem-
onstrated by electron microscopy images of the telopodes (Figure 6) [70]. Homo-
cellular junctions are typically established between two telopodes, but might be 
observed between a telopode and a TCs’ body [71]. The most frequently observed 
interactions are simple appositions of the plasma membranes; however, puncta 
adhaerentia minima, processus adhaerens, recessus adhaerens, and manubria 
adhaerentia can be captured in electron microscopy images [10, 18]. Sometimes, 
even gap junctions were captured [18]. Hetero-cellular junctions are usually seen 
between telopodes and fibroblasts, myofibroblasts, pericytes, stem cells, mac-
rophages, mast cells, lymphocytes, plasma cells, Schwann cells, endothelial cell, 
neurons, cardiomyocytes, and smooth muscle cells, as described in the literature 
[12, 56, 72–74]. The contacts made between the two membranes are of the type 
of point contacts, nanocontacts, planar contacts, or simple apposition of plasma 
membranes [18].
TCs can release exosomes (from multivesicular bodies), ectosomes (shredded 
directly from plasma membrane), and multivesicular cargos (multiple tightly 
packed endomembrane-derived vesicles) [75]. The three types of extracellular 
vesicles emitted by TCs are evidence of the involvement of these cells in intercel-
lular distance communication. Shed vesicle number and diameter are not correlated 
with the reproductive state, while the quantity of TCs in the endometrium and the 
myometrium varies with it [17]. Moreover, it was demonstrated that the morphol-
ogy of telopodes is correlated with the presence or absence of gestation [70].
All these morphological, immunohistochemical, and electrophysiological 
observations have led to several hypotheses on the TC functions in the uterus and 
fallopian tubes. The existence of homo-cellular junctions leads to a presumptive 
function in controlling the shape of the tissues which are subjected to of dynamic 
changes, such as the pregnant uterus that hypertrophies and expands as the 
fetus grows [17]. In support of this assumption stands the hypothesis that TCs 
contribute to smooth muscle growth in areas with high mechanical forces due to 
TCs mechanical sensitivity [76]. The mechano-sensing function should also be 
considered, due to the presence of catenins that make up the junctions [18, 71]. 
Moreover, TCs express T-type calcium (CaV3.1 and CaV3.2) channels and small-
conductance calcium-activated potassium channels (SK3) and calcium-dependent 
hyperpolarization-activated chloride inward channels, the levels of expression 
being dependent on the physiological state, pregnant or non-pregnant [70, 77, 78]. 
This point to a TCs’ involvement in calcium signaling mechanisms with neighbor-
ing cells [79]. Extracellular matrix remodeling is also emphasized by some studies 
and can be considered as applicable to the uterus [80, 81]. The existence of (ERα) 
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and progesterone receptor A (PR-A) on the surface of uterine TCs suggests their 
involvement as sensors for steroid hormones levels. Although little is known about 
the existence of stem cells in the uterus, they certainly exist, and the secretome of 
the TCs could influence the cellular microenvironment, controlling their prolifera-
tion, and differentiation [15]. Also, TCs secretome factors could participate in 
decidua formation [17]. Some studies pointed to the angiogenic properties of TCs 
Figure 6. 
Representative ultrathin section of human pregnant myometrium. Two-dimensional sequenced concatenation 
from 11 serial electron micrographs showing the 3D network of TCs (blue) interconnected by homo-cellular 
junctions (dotted circles). SMCs are shown in cross-section and were digitally colored brown. In their vicinity, 
numerous Tps (blue) establish a network and release extracellular organelles (exosomes and shedding vesicles 
[arrowheads]) digitally colored purple. One mast cell (green) is in the vicinity of this network. Some vesicles 
were captured at the moment of being shed from Tps (*). Cav = caveolae; coll = collagen; m = mitochondria; 
rER = rough endoplasmic reticulum; N¼nucleus. Bar¼2 lm. Reproduced with permission from Ref. [10].
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due to vascular endothelial growth factor (VEGF) expression [15, 82, 83], while 
others indicated the anti-oxidative properties of TCs because the TCs specific mor-
phology can be changed by modifying the redox balance of their environment or by 
aging due to their richness in SOD2 (mitochondrial superoxide dismutase) [21, 84].
Recently, TCs were found to activate and “educate” peritoneal macrophages 
(pMACs) with the aid of telopodes by direct physical contact through hetero- 
cellular junctions or using a TCs-conditioned media through paracrine mecha-
nisms [85]. This is suggestive for a role in immunosurveillance [85].
In the fallopian tubes, TCs have been described throughout the thickness of 
the wall, their density decreasing from the mucosa to the muscular, from ∼18 to 
∼7.5% [3]. TCs are also found in the fimbriae of Fallopian tubes [17, 28]. A panel 
of antibodies was used to identify tubal TCs. The telopodes possess all the features 
described above, creating a 3D network and establishing contacts with different 
structures, such as blood vessels, nerves, and muscle fibers [86, 87]. Both, homo- 
and hetero-cellular junctions are described, and also, a new hypothesis was emit-
ted that telopodes that contact the immune cells (plasma cells and lymphocytes) 
might stimulate antibody production [88, 89]. As suggested by Cretoiu et al., 
the tubal peristalsis might suffer influences from TCs which also express PR-A 
and ERα receptors [31]. The tubal movements seem to be amplified by estrogen 
and decelerated by progesterone [90]. Recently, additional markers were tested 
for TCs identification, such as Podoplanin (D2–40) and Dog-1 but proved to be 
inappropriate [91].
4.2 Telocytes in uterine and tubal diseases
The pathogenesis of uterine leiomyomas, the most frequent benign tumors in 
women might be determined, among other factors, by the loss of TCs [26]. Varga 
et al. proposed three hypotheses regarding TCs’ involvement: (i) loss of TCs as 
steroid sensors leads to an increased density of estrogen receptors at smooth muscle 
cells level followed by a cell cycle disruption; (ii) considered as progenitor cells, 
TCs absence can favor the rise of new leiomyoma cells; and (iii) in the absence of 
antioxidant protection conferred by TCs, leiomyoma cells grow numerically due to 
local hypoxia that blocks their apoptosis [26].
A recent study shows, for the first time, that there is an interplay between 
telocytes and autonomic innervation in leiomyomata [92]. TCs decreased in numbers 
in the leiomyomatous myometrium, suggesting a role for these cells in the control 
of the microenvironment [92].
The integrity of the 3D network of TCs appears to be fundamental in exercising 
the function of the fallopian tubes that are regarded as a major organ in the repro-
duction. Several studies showed that by affecting the 3D organization and number 
of TCs perturbations occur in the local homeostasis, leading to angiogenesis and 
interstitial fibrosis [88, 89]. Neo-angiogenesis plays a major role in endometriosis 
and adenomyosis pathogenesis, and even in tubal ectopic pregnancy [93–95]. TCs 
were shown to be involved in all these processes [96, 97]. In pelvic endometriosis 
and tubal ectopic pregnancy, the decrease in the number of TCs is probably due to 
the overproduction of iNOS, COX-2, LPO, and estradiol [49, 69, 88].
Some other pathologies that might affect the 3-D network of TCs were 
described, such as Chlamydia infection responsible for the activation of macro-
phages or pelvic inflammatory disease [89, 98, 99]. In inflammation and ischemia, 
TCs were shown to be lost and to suffer major ultrastructural changes, a process 
followed by interstitial fibrotic remodeling [99]. Abd-Elhafeez et al. proposed a 
role for tubal TCs in the regulation of the epithelial function necessary for the final 
gamete maturation, fertilization, and early embryo development [100].
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5. Heart
Cardiac TCs are among the most well described in the body [101]. Cardiac TCs 
are unique interstitial cells in the heart [101]. Intramyocardial TCs account for less 
than 1% of interstitial cells in the human heart [56]. Cardiac TCs have been identi-
fied in heart valves, left and right atrium and ventricle, epicardium, myocardium, 
endocardium, sub-endocardium, and myocardial sleeves [101, 102], in mice, rat, 
porcine, and human [56, 103]. The whole ultrastructural anatomy of human cardiac 
TCs has been reconstructed by focused ion beam scanning electron microscopy 
(FIB-SEM) [104]. The electrophysiology of human cardiac atrial and ventricular 
TCs has also been reported [105].
Cardiac TCs are completely different from other types of myocardial interstitial 
cells, especially from cardiac fibroblasts [106]. Cardiac TCs and cardiac fibroblasts 
are completely different in immunophenotypes, as cardiac TCs are positive for CD34/
PDGFR-ɑ, CD34/PDGFR-ß, or CD34/Vimentin while cardiac fibroblasts are only 
positive for PDGFR-ß and Vimentin [106]. CD34/PDGFR-ɑ positive TCs account for 
one-third of the total cells among TCs enriched rat cardiac interstitial cell population 
[106, 107]. Some studies have also reported that cardiac TCs inconstantly express 
CD34/c-kit [56]. Besides, cardiac TCs are also distinct from pericytes, since cardiac 
TCs are CD34 positive and ɑ-SMA weak positive while pericytes are CD34 negative 
and ɑ-SMA positive [106]. Moreover, cardiac TCs are CD34/PDGFR-ß positive while 
pericytes are CD34 negative and PDGFR-ß positive [106]. Interestingly, cardiac TCs 
are positive for CD29 (a mesenchymal marker) but negative for CD45 (a hematopoi-
etic marker), suggesting that cardiac TCs could be a source of cardiac mesenchymal 
cells [106]. Interestingly, the telomerase concentration in CD117 and CD34 positive 
cardiac TCs is significantly higher than that in cardiomyocytes and is 2.5-times and 1.5-
times lower than that in bone mesenchymal stem cells and cardiac fibroblasts [108].
Cardiac TCs can form tight junctions with all other types of cells within the 
heart including cardiomyocytes, vascular smooth muscle cells, endothelial cells, 
and pericytes. The functions of cardiac TCs are not fully known but are proposed as 
follows: (1) intercellular signaling; (2) mechanoreceptors/transducers; and (3) car-
diac homeostasis and repair [101, 109]. In the heart, telocytes participate in cardiac 
development and physiology, and diverse cardiovascular diseases (Figure 7).
Figure 7. 
Cardiac telocytes are in tandem with different types of cells in the heart, and participate in cardiac 
development and physiology, and diverse cardiovascular diseases. ECM, extracellular matrix; VSMCs, 
vascular smooth muscle cells.
15
Telocytes: New Connecting Devices in the Stromal Space of Organs
DOI: http://dx.doi.org/10.5772/intechopen.89383
5.1 Cardiac telocytes in heart development and physiological growth
Involvement of cardiac TCs and cardiomyocytes during development have been 
investigated using myocardium from embryonic (E14, E17), newborn (P0, P6), and 
adult (2 months) CD1 mice by using transmission electron microscopy and immu-
nohistochemistry [110]. It was found that TCs were present from early embryonic 
to adult life in the mouse heart [110]. Besides, cardiac TCs demonstrated immature 
features in early embryonic hearts while cardiac TCs exhibit a more differenti-
ated phenotype in newborn hearts [110]. Cardiac TCs played a fundamental role 
during cardiac development by forming a correct three-dimensional myocardial 
architecture and nursing cardiomyocyte precursors [110]. Intriguingly, cardiac TCs 
were found negative for c-kit and CD34 during the embryonic stage [110]; however, 
CD34 was expressed in a few TCs in the heart of a newborn mouse, and in most 
TCs in adult hearts [110]. This suggests a phenotype switch of cardiac TCs during 
development.
Exercise can induce cardiac physiological growth, which is characterized by 
increased cell size of cardiomyocytes and the formation of new cardiomyocytes 
[111, 112]. Three double-immunostainings, including CD34/PDGFR-ɑ, CD34/
PDGFR-ß-, and CD34/vimentin, have been used to determine the number of 
cardiac TCs in exercise-induced physiological cardiac growth [81]. The number of 
cardiac TCs was found to be significantly increased in the exercised heart [81]. The 
increased cardiac TCs in exercise might communicate with cardiomyocytes through 
direct contacts or telocyte-shed vesicles, balance angiogenesis, and maintain the 
normal 3D-organization of ECM [81]. This study suggested a potential role of 
cardiac TCs in exercise-induced cardiac growth [81].
5.2 Cardiac telocytes in cardiovascular diseases
Isolated atrial amyloidosis (IAA) is frequently found in long-standing atrial 
fibrillation patients [113]. By electron microscopy, telopodes are found surrounding 
the amyloid deposits, which limit their spreading into the interstitium [113]. This 
indicates that TCs might participate in amyloidogenesis by gathering masses of 
amyloid fibrils.
Systemic sclerosis represents a complex connective tissue disease featured with 
fibrosis of the skin and various internal organs [54]. TCs, as defined by CD34-
positivity/CD31-negativity, were checked in the fibrotic areas of systemic sclerosis 
myocardium and were found to be almost undetectable [54]. However, in the 
control myocardium, numerous TCs were found located in the interstitium sur-
rounding cardiomyocytes [54]. This indicates that loss of cardiac TCs contributes to 
myocardial fibrosis caused by systemic sclerosis.
The imbalance between cardiac TCs apoptotic death and cardiac TCs prolifera-
tion is responsible for the depletion of cardiac TCs in cardiac diseases leading to 
heart failure [52]. In human heart failure patients’ myocardium, the number of 
cardiac TCs and telopodes decreases over twofold. Additionally, the apoptotic 
cardiac TCs increases threefold in the diseased heart while the percentage of prolif-
erating cardiac TCs remains unchanged, suggesting that the decreased cardiac TCs 
population in heart failure is mainly due to increased apoptosis [52]. Interestingly, 
the number of cardiac TCs and telopodes has been found to depend on the composi-
tion of the extracellular matrix which is correlated negatively with mature fibrillar 
collagens and positively with degraded collagens [52].
The changes of cardiac TCs have been determined in an acute myocardial 
infarction rat model induced by isoproterenol (ISO) [114]. It was found that 
CD117/CD34 positive cardiac TCs were undetectable with immunohistochemical 
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staining 1 day after ISO treatment. Interestingly, treatment with grape seed 
extract (GSE) could significantly increase cardiac TCs numbers and enhance 
angiogenesis in myocardia but not in other tissues; in fact, it was found sup-
pressing angiogenesis in tumor tissues instead [114]. Thus, GSE was regarded to 
promote angiogenesis by modulating cardiac TCs, which subsequently stimulated 
endothelial cells [114].
Also, in a rat myocardial infarction model induced by coronary occlusion, car-
diac TCs were reported undetectable in the infarction zone from 4 days to 4 weeks 
[115]. Simultaneous transplantation of cardiac TCs could significantly decrease 
infarct size and improve heart function 2 weeks after myocardial infarction [115]. 
Moreover, the protective effects of intramyocardial transplantation of cardiac TCs 
were also observed 14 weeks after myocardial infarction as evidenced by improved 
heart function, decreased infarct size, increased angiogenesis, and decreased 
myocardial fibrosis [116].
Currently, no single specific immunophenotype for cardiac TCs has been 
identified [101]. For in-depth studies of cardiac TCs, it is highly needed to identify a 
specific immunostaining marker for them. Most isolated cardiac TCs are either not 
pure enough (as cardiac fibroblasts grow much faster than cardiac TCs) or only con-
taining subtypes of cardiac TCs. It would be beneficial to investigate the therapeutic 
effects of cardiac TCs or cardiac TCs-derived exosomes. Moreover, the immuno-
regulatory effects of cardiac TCs should be thoroughly investigated. Finally, other 
organs or tissue-specific TCs are worthy to be studied.
6. Conclusion and future overlook for telocytes’ study
In conclusion, this review of the literature data indicates that TCs, depending on 
their location, may display different immunohistochemical properties, ultrastruc-
tural peculiarities and form complex networks making contacts either between 
themselves or with other cell types. Further, our current knowledge of TCs allows 
the following conclusions on the role(s) that these cells may play, some of which 
might be common to the different organs and some be organ-/region-specific.
1. In the stromal space of all the organs taken into account, TCs appear as 
connecting cells. Reasonably, TCs, due to their homo- and hetero-cellular 
contacts, can be considered as connecting devices playing either common or 
region-specific roles. These contacts might be merely mechanical or sites of 
cross-talking between TCs and other cell types establishing intercellular mo-
lecular exchanges. Spatial relationships also suggest an involvement of the TCs 
network in the coordination of tissue homeostasis in response to local func-
tional demands.
The involvement in tissue homeostasis might be explained by the heterogeneity 
of TCs depending on their location.
2. TCs might be engaged in controlling the proliferation and differentiation of the 
stem cells and, either in the adulthood or during organ differentiation, wher-
ever they are located, these cells might be considered as a pool of mesenchymal 
stromal cells
As an example, in the gastrointestinal tract and the urinary bladder, the subepi-
thelial plexus formed by TCs likely supports the stem cell proliferation and epithe-
lial renewal and, the TCs located in the muscle coat, might differentiate into ICCs 
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and, undergoing to phenotypic changes, become a cell source of gastrointestinal 
stromal tumors such as GIST. A shift toward a myofibroblast phenotype has been 
proposed for the TCs located in the urinary bladder lamina propria.
In the female genital tract, although there are no reported interactions with stem 
cells, a role for TCs in this direction cannot be overlooked because neo-angiogenesis 
undoubtedly accompanies myometrial hypertrophy.
Moreover, in the heart, a special inter-relation exists between TCs and cardiac 
stem cells based on the exchange of information via extracellular vesicles which 
shuttle miRNA or by direct connections through typical and atypical junctions. The 
secretome of TCs might enhance the proliferation and differentiation of cardiac 
stem cells. Suggestions were also made regarding the possibility of their role in 
the re-activation of dormant myocardial precursors during the repair of the adult 
heart, while in embryo TCs act as inductors/regulators of differentiation during 
morphogenesis.
3. The TCs scaffold located in all the hollow organs follows organ distension and 
relaxation likely to avoid anomalous organ deformation and to control blood 
vessels closure or rheology. This is a mechanical role whose importance has been 
demonstrated in some gastrointestinal pathologies, where TCs loss provokes 
severe architectural derangement and contributes to the altered 3D ECM 
organization in the fibrotic intestinal wall. In the uterus, TCs can function as a 
sensor for the mechanical stress exerted on the uterine wall, allowing uniform 
uterine growth during pregnancy, by mechanosensitive coordination due to 
the existence of different ionic channels which can be modulated by pharma-
cological interventions.
Moreover, TCs can also be regarded as chemical sensors as it was hypothesized 
for the human uterus and fallopian tube, where TCs might play an important role in 
the uterine contraction mechanism due to the presence of estrogen and progester-
one receptors at their level.
4. Because of the anatomical complexity of the hollow organs and the great 
variety of cell populations interacting with the TCs, many different and organ-
specific TCs roles are conceivable suggesting that these cells might take center 
stage in the integration of the overall interstitial information from the vascular, 
nervous, and immune systems, as well as from tissue-resident stem cells
In the gastrointestinal tract, a particular role is played by the intramuscular 
hetero-cellular TCs network in supporting the spreading of the slow waves generated by 
the ICCs, which are electrically coupled to the smooth muscle cells, thus contribut-
ing to the regulation of gastrointestinal motility. In agreement with this hypothesis 
is the evidence that the simultaneous reductions in the TCs and ICCs account for the 
intestinal dysmotility characterizing the IBD. In the urinary bladder, the sub-uro-
thelial TCs likely play a role as intermediaries in propagating chemical or electrical 
stimuli locally generated being the target of the paracrine activity of the urothelium 
and the nervous system. The importance of these roles is plenty understood since 
the ULP and the urothelium constitute a sensory system capable of perceiving 
mechanical and chemical stimuli and whose integrated responses control the effer-
ent pathways on the detrusor and the micturition, responses that are lost in urinary 
pathologies such as the NDO.
In female genital tract, TCs seems to lack in regular slow waves indicating that 
they are not involved in triggering or supporting the peristalsis of these organs, but 
more detailed studies are necessary.
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